Nitric oxide depresses connexin 43 after myocardial infarction in mice

P E M Jackson1, Q P Feng, D L Jones

  • 1Department of Physiology, University of Western Ontario, London, ON, Canada.

Insights

Increased nitric oxide (NO) from inducible nitric oxide synthase (iNOS) worsens heart failure by reducing cardiac connexin 43 (Cx43) levels and impairing heart function. This study investigated the iNOS-Cx43 link in mouse models of myocardial infarction.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cardiac Pathophysiology

Background:

  • Heart failure (HF) is a significant cause of mortality and morbidity.
  • Reduced cardiac connexin 43 (Cx43) is observed in failing hearts, but its regulators are unknown.
  • High nitric oxide (NO) levels, induced by inducible nitric oxide synthase (iNOS), are implicated in HF-related apoptosis and dysfunction.

Purpose of the Study:

  • To investigate the relationship between inducible nitric oxide synthase (iNOS) and connexin 43 (Cx43) in the context of myocardial infarction (MI).
  • To determine the impact of iNOS-derived NO on cardiac function and Cx43 expression post-MI.

Main Methods:

  • Myocardial infarction was induced in wild-type and iNOS knockout mice.
  • Cardiac function was assessed using left ventricular catheterization.
  • Myocardial Cx43 and Cx45 protein levels were quantified via immunofluorescence and Western blotting.
  • Primary cardiomyocyte cultures were used to assess the direct effect of NO on Cx43 expression.

Main Results:

  • Mice lacking iNOS exhibited improved hemodynamic performance and reduced mortality after MI compared to wild-type mice.
  • Myocardial Cx43 content was significantly reduced in wild-type mice post-MI, with a less pronounced reduction in iNOS knockout mice.
  • In vitro, NO donors decreased Cx43 levels in cultured cardiomyocytes in a dose-dependent manner.

Conclusions:

  • Increased NO production by iNOS exacerbates cardiac dysfunction and contributes to decreased myocardial Cx43 content following myocardial infarction.
  • Targeting iNOS or NO signaling may represent a therapeutic strategy for heart failure.
Abstract